Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The price of Repligen Corp (NASDAQ: RGEN) closed at $167.53 in the last session, down -1.10% from day before closing price of $169.40. In other words, the price has decreased by -$1.10 from its previous closing price. On the day, 0.58 million shares were traded. RGEN stock price reached its highest trading level at $177.17 during the session, while it also had its lowest trading level at $166.55.
Ratios:
We take a closer look at RGEN’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 11.97 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 71.51. For the most recent quarter (mrq), Quick Ratio is recorded 8.76 and its Current Ratio is at 10.44. In the meantime, Its Debt-to-Equity ratio is 0.33 whereas as Long-Term Debt/Eq ratio is at 0.33.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Canaccord Genuity on December 17, 2024, initiated with a Hold rating and assigned the stock a target price of $165.
On August 28, 2024, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $180.Wells Fargo initiated its Overweight rating on August 28, 2024, with a $180 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 21 ’24 when Hunt Anthony sold 24,246 shares for $139.67 per share. The transaction valued at 3,386,439 led to the insider holds 139,840 shares of the business.
Anthony Hunt bought 24,246 shares of RGEN for $3,386,311 on Nov 21 ’24. On Sep 10 ’24, another insider, Hunt Anthony, who serves as the Director of the company, sold 22,191 shares for $145.37 each. As a result, the insider received 3,225,927 and left with 139,840 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RGEN now has a Market Capitalization of 9386152960 and an Enterprise Value of 9316475904. For the stock, the TTM Price-to-Sale (P/S) ratio is 14.82 while its Price-to-Book (P/B) ratio in mrq is 4.65. Its current Enterprise Value per Revenue stands at 14.559 whereas that against EBITDA is 92.742.
Stock Price History:
The Beta on a monthly basis for RGEN is 0.99, which has changed by -0.13646328 over the last 52 weeks, in comparison to a change of 0.21794415 over the same period for the S&P500. Over the past 52 weeks, RGEN has reached a high of $211.13, while it has fallen to a 52-week low of $113.50. The 50-Day Moving Average of the stock is 10.37%, while the 200-Day Moving Average is calculated to be 13.51%.
Shares Statistics:
According to the various share statistics, RGEN traded on average about 589.31K shares per day over the past 3-months and 683020 shares per day over the past 10 days. A total of 56.03M shares are outstanding, with a floating share count of 52.13M. Insiders hold about 6.96% of the company’s shares, while institutions hold 99.76% stake in the company. Shares short for RGEN as of 1736899200 were 3239781 with a Short Ratio of 5.50, compared to 1734048000 on 3194031. Therefore, it implies a Short% of Shares Outstanding of 3239781 and a Short% of Float of 6.760000400000001.
